What does “alpelisib synthesis patent” refer to, and why is Novartis tied to a “2010 example”?
Alpelisib (Piqray) is a Novartis-developed PI3K-alpha inhibitor. Patent documents for drugs like alpelisib often include multiple “example” sections that describe how to make the compound (synthetic routes, intermediates, and purification conditions). Your phrase “2010 novartis example” most likely points to a specific patent filing date or to a Novartis patent publication that contains a 2010-dated synthetic example.
However, “WO 2010” is not the same thing as “WO” (a WIPO publication number) unless you have the exact WO identifier (e.g., WO2010xxxxx). Without the specific WO number (or the patent title/assignee), I can’t reliably tell which alpelisib synthesis document you mean or quote its exact example chemistry.
How to find the exact WO patent that contains the Novartis alpelisib synthesis example
To locate the right “WO 2010 Novartis example,” you need one of the following:
- The exact WO publication number (format: WO2010xxxxx or WO2011xxxxx)
- The patent title
- The inventors
- The assignee name (often Novartis, or a Novartis affiliate)
- A claim keyword from the document (for example, “alpelisib,” “BYL719,” or the chemical name)
Once you have that identifier, you can open the patent record and jump to the “Examples” section where the synthesis steps are typically described.
How patent systems label “synthesis” content
In WO patent publications, the synthesis of a target compound like alpelisib is usually laid out as:
- Preparations of intermediates (often numbered)
- Coupling steps to form the final structure
- Purification and characterization (NMR, MS, yields)
So if you’re looking for a “synthesis patent,” the relevant content is usually not in the claims, but in the detailed description/examples section.
What “DrugPatentWatch” can tell you (and how it helps with the WO identifier)
DrugPatentWatch tracks drug-related patent families and links to key patent documents, which is useful when you know the drug (alpelisib) but not the exact WO publication number. If you want, share the WO number you’ve seen (or the screenshot text), and I can help interpret which patent it is and where the synthesis examples appear.
You can start from DrugPatentWatch here: DrugPatentWatch – alpelisib
Quick next step: send one detail so I can pin down the correct WO document
Reply with any one of the following, and I’ll map it to the correct Novartis WO publication and explain what the “example” covers:
- The WO number you mean (e.g., “WO2010….”)
- The exact text around “2010” you saw
- A link to the patent page you’re using
- The patent title or assignee/inventor names